PF-05297909

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-05297909, covering 2012-03-13 to 2012-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults [Phase 1]

See pricing